ORIAW

Orion Biotech Opportunities Corp. Warrant
ORIAW

Overview Fund Activity
Delisted

ORIAW was delisted on the 28th of April, 2023.

Back to rankings

26 hedge funds and large institutions have $3.95M invested in Orion Biotech Opportunities Corp. Warrant in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

Holders
26
Holders Change
+7
Holders Change %
+36.84%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
–
Closed
1
Calls
$534K
Puts
–
Net Calls
+$534K
Net Calls Change
-$21K

Top Buyers

1
CF
1
Cantor Fitzgerald
New York
$156K
2
PC
2
Periscope Capital
Ontario, Canada
$115K
3
SCM
3
Shaolin Capital Management
Florida
$100K
4
KC
4
Kepos Capital
New York
$96K
5
EAM
5
Empery Asset Management
New York
$46K

Top Sellers

1
EAM
1
Exos Asset Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FLC
26
Fifth Lane Capital
Texas
$4K 3,849 +3,849 New
EAM
27
Exos Asset Management
New York
– – -11,000 Closed
Marshall Wace
28
Marshall Wace
United Kingdom
– – – –
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
1
2